OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics

Rhea-AI Summary

OrthoPediatrics (NASDAQ: KIDS) announced significant expansion of its Specialty Bracing (OPSB) division through multiple new clinics and territory entries. The company has established its first California clinic in Los Angeles, opened a new facility in Dayton Children's Hospital, and expanded into the Denver, Colorado territory.

Through Acquihire opportunities, OPSB added multiple locations in New York City within major Children's Hospital centers and entered its first international market in Ireland. The Irish expansion complements OrthoPediatrics' existing implant business presence and creates opportunities for further European expansion.

Positive

• Geographic expansion into 4 new target markets ahead of 2025 schedule
• Entry into first international market (Ireland) with potential for European expansion
• Strategic positioning within major Children's Hospital centers
• Access to millions of new potential pediatric patients in Los Angeles market

Negative

• None.

Insights

Healthcare Business Analyst

OrthoPediatrics expands bracing division into five new territories including first international market, significantly enlarging patient reach.

OrthoPediatrics is executing a significant operational expansion of its Specialty Bracing division (OPSB), strategically positioning itself in five new territories including California, Ohio, Colorado, New York, and Ireland. The Ireland entry marks OPSB's first international market, complementing the company's existing implant business presence there and creating a foundation for broader European expansion.

This expansion follows a dual-pronged strategy: greenfield clinic development in domestic markets and "acquihire" opportunities to accelerate growth in New York and Ireland. The Los Angeles market entry alone provides access to millions of potential pediatric patients, while the New York operation added multiple locations to existing clinics, all strategically positioned within major Children's Hospital centers.

The company is ahead of schedule on its 2025 market expansion targets, suggesting strong execution capabilities. By locating clinics directly within children's hospitals (like Dayton Children's Hospital), OPSB creates integrated care pathways that can drive both patient satisfaction and potential referral volumes.

This expansion directly addresses what management describes as an "unmet need" in pediatric bracing and O&P (Orthotic and Prosthetic) care. The endorsement from Dayton Children's Hospital's Division Chief validates the company's approach, with on-site care coordination likely improving both clinical outcomes and operational efficiency.

From a business perspective, this expansion substantially increases OPSB's addressable market while maintaining focus on its pediatric orthopedics niche, where the company faces less competition from general orthopedic giants.

WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) division with multiple new clinics and entry into two new territories.

The expansion of the OPSB division includes rapid expansion of greenfield clinic locations in California, Ohio, and Colorado.

• Entered a new territory with OPSB’s first clinic in California. The Los Angeles market provides access to millions of potential pediatric and adolescent patients.
• Opened a new clinic in Dayton, OH, providing skilled clinicians within Dayton Children’s Hospital and expanding the Ohio territory.
• Added new clinics and experienced clinicians to cover the expansive Denver, CO territory.
  

OPSB continues to expand through Acquihire opportunities by adding two new operations in New York and Ireland.

• The greater New York City operation added multiple patient locations to the existing two clinics; all new clinics are located within major Children’s Hospital centers. This strategic position will allow a seamless synergy between the clinicians and pediatric surgeons.
• Ireland represents both a new territory and OPSB’s first international market. This location is complimentary to OrthoPediatrics’ strong implant business presence in one of the country’s largest pediatric hospitals and provides opportunities to expand to additional Ireland based clinics and beyond across the European region.

Joe Hauser, OrthoPediatrics Specialty Bracing division President, commented, “We are thrilled to announce this continued expansion as we are slightly ahead of our planned entry into 4 new target markets in 2025. Our vision to provide better bracing and O&P care to kids across the world is materializing by providing access to millions of potential new patients. I continue to be impressed by the response from surgeons, partnering hospitals, O&P clinicians, and parents, we are clearly filling an unmet need. Our impressive clinical team continues to grow, adding new team members while they increase their knowledge in the pediatric and adolescent space”.

Michael C. Albert MD, Division Chief of Pediatric Orthopedics at Dayton Children’s Hospital shared in the excitement, “OrthoPediatrics has always been dedicated to the needs of children and this next step forward, focusing on bracing and O&P care, advances this mission. Their dedication to this space and expanding patient access is key. Partnering with OPSB to bring O&P care on-site will greatly benefit all our patients and our community.  We are extremely happy to have them here”.

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.

Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406

FAQ

What new territories has OrthoPediatrics (KIDS) expanded into in 2025?

OrthoPediatrics has expanded into California (Los Angeles), Ohio (Dayton), Colorado (Denver), New York City, and Ireland, with the latter being their first international market.

How many new clinics did OrthoPediatrics (KIDS) add in 2025?

OrthoPediatrics added multiple clinics across California, Ohio, Colorado, New York City, and Ireland, including locations within major Children's Hospital centers.

What is the significance of OrthoPediatrics' expansion into Ireland?

The Ireland expansion marks OPSB's first international market, complementing their existing implant business and providing opportunities for further expansion across Europe.

How will the Los Angeles clinic benefit OrthoPediatrics (KIDS)?

The Los Angeles clinic provides access to millions of potential pediatric and adolescent patients in the California market.

What is the strategic advantage of OrthoPediatrics' new clinic locations?

The clinics are strategically located within major Children's Hospital centers, allowing seamless synergy between clinicians and pediatric surgeons.